Aura Biosciences (AURA) Non Operating Income (2021 - 2026)

Aura Biosciences' Non Operating Income history runs 6 years deep, the most recent figure standing at $1.2 million for Q1 2026.

• Quarterly Non Operating Income fell 24.08% year-over-year to $1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.3 million (down 23.05% YoY) and the FY2025 annual result came in at $6.7 million, down 27.94% from the prior year.
• Non Operating Income was $1.2 million for Q1 2026 at Aura Biosciences, down from $1.7 million in the prior quarter.
• Across five years, Non Operating Income topped out at $2.8 million in Q4 2023 and bottomed at -$24000.0 in Q1 2022.
• A 5-year average of $1.6 million and a median of $1.8 million in 2025 frame the typical range for Non Operating Income.
• Annual changes were most pronounced in 2022 — Non Operating Income surged 15157.14% — and 2025, when it slumped 40.82%.
• Aura Biosciences' Non Operating Income stood at $1.1 million in 2022, then soared by 164.61% to $2.8 million in 2023, then decreased by 28.4% to $2.0 million in 2024, then declined by 15.22% to $1.7 million in 2025, then decreased by 29.59% to $1.2 million in 2026.
• Business Quant data shows AURA's Non Operating Income at $1.2 million in Q1 2026, $1.7 million in Q4 2025, and $1.8 million in Q3 2025.